<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiovascular (CV) diseases are known to have a negative impact on the brain and neurocognition, and contribute to the development of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> such as <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>Among CV diseases, <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) after <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (MI) is a condition where the ability of the left ventricle to eject blood to the circulation is impaired </plain></SENT>
<SENT sid="2" pm="."><plain>As a consequence, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> triggers <z:mp ids='MP_0001845'>inflammation</z:mp> and results in reduced cerebral blood flow which are considered among the risk factors for development of AD </plain></SENT>
<SENT sid="3" pm="."><plain>However, biochemical alterations in the brain following MI and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> remain unknown </plain></SENT>
<SENT sid="4" pm="."><plain>To address this issue, we investigated microglia activation; levels of BACE1, the key rate-limiting enzyme involved in the pathogenesis of AD; and VEGF levels in the hippocampus and cortex following MI </plain></SENT>
<SENT sid="5" pm="."><plain>We created MI by the ligation of the left anterior descending coronary artery in Sprague-Dawley male rats and collected brains either 3 days after MI (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e>) or 21 days after MI (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain>We investigated microglia activation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> brains by immunohistochemistry and immunoblotting using macrophage/microglia marker Ionized calcium binding adaptor molecule 1 (Iba-1), and observed activated <z:mp ids='MP_0000002'>morphology</z:mp> of microglia in the cortex of rats in both <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AMI</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>We also showed the levels of BACE1 were increased in the cortex and hippocampus of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> rats </plain></SENT>
<SENT sid="8" pm="."><plain>To determine whether <z:mp ids='MP_0005039'>hypoxia</z:mp> occurs in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> brain, we assessed levels of VEGF in the hippocampus and cortex </plain></SENT>
<SENT sid="9" pm="."><plain>Western blotting analysis showed up-regulation of VEGF in the hippocampus of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> brains </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that neuroinflammation takes place secondary to <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>In addition, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e>-induced <z:mp ids='MP_0005039'>hypoxia</z:mp> might play a role in the elevation of BACE1 and VEGF levels </plain></SENT>
</text></document>